This Cooperative Agreement award from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $1 million to Itherapy, LLC of Martinez, California to develop an evaluative artificial speech intelligence and autism screener system called EASI-AS. The system aims to improve treatment for children with communication impairments by providing specialists and parents with accurate, efficient reports on speech and language evaluations along with recommendations. Key objectives include improving machine learning modules for language proficiency assessment, recommendation generation, child voice and accent recognition, and intonation detection. The award also supports developing an autism screener using eye tracking technology and a web/mobile platform for data collection from children. The two-year project period runs from May 1, 2022 to April 30, 2024.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $1.0m | 4/27/22 |